CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022Ruihao Huang, Xi Zhang, Qin Wen|Journal of Hematology & Oncology|2023Cited by 45
Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I TrialRuihao Huang, Xi Zhang, Maihong Wang et al.|Blood|2022Cited by 33
The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient SurvivalXin Li, Jiang F. Zhong, Yi Xu et al.|Cancers|2022Cited by 16
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangementYi Xu, Jiang F. Zhong, Esther G Chong et al.|Drug Resistance Updates|2025Cited by 3